TETRALOGIC PHARMACEUTICALS CORP Business Acquisition, Pro Forma Earnings Per Share, Basic
TETRALOGIC PHARMACEUTICALS CORP reported Business Acquisition, Pro Forma Earnings Per Share, Basic of -$0.26 per share for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-08.
Discontinued › Income Statement › Earnings Per Share
us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic · last filed 2014-05-08
- TETRALOGIC PHARMACEUTICALS CORP business acquisition, pro forma earnings per share, basic for the quarter ending 2014-03-31 was -$0.26.
- TETRALOGIC PHARMACEUTICALS CORP business acquisition, pro forma earnings per share, basic for the quarter ending 2013-03-31 was -$4.30.
| Period end | Business Acquisition, Pro Forma Earnings Per Share, Basic 3 month |
|---|---|
| 2014-03-31 | -$0.26 10-Q · filed 2014-05-08 |
| 2013-03-31 | -$4.30 10-Q · filed 2014-05-08 |